AnaptysBio, Inc. (ANAB) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.61B, a trailing price-to-earnings ratio of 87.0 and a free-cash-flow yield of 1.3%. Over the most recent reported fiscal year, revenue grew 157.0%.